Rankings
▼
Calendar
SLDB Q2 2024 Earnings — Solid Biosciences Inc. Revenue & Financial Results | Market Cap Arena
SLDB
Solid Biosciences Inc.
$644M
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$28M
Net Income
-$25M
EPS (Diluted)
$-0.61
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$21M
Free Cash Flow
-$22M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$231M
Total Liabilities
$38M
Stockholders' Equity
$193M
Cash & Equivalents
$96M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$28M
-$27M
-3.5%
Net Income
-$25M
-$25M
-1.8%
← FY 2024
All Quarters
Q3 2024 →